Astrazeneca Pharma India Shares Dive Nearly 7% As Vaccine Trials Paused

The parent company AstraZeneca "voluntarily paused" a randomized clinical trial of its coronavirus vaccine asa volunteer developed an unexplained illness.

from NDTV Profit - Latest https://ift.tt/2F5x0Wm
via